Iridex (IRIX) Acquisitions (2011 - 2022)

Iridex's (IRIX) quarterly Acquisitions came in at -$5.3 million in Q4 2022, down 200.0% quarter-over-quarter from $5.3 million in Q2 2021.

Iridex (IRIX) Acquisitions (2011 - 2022) Analysis & Trends

Iridex's Acquisitions history runs 3 years deep, the most recent figure standing at -$5.3 million for Q4 2022.

On a quarterly basis, Acquisitions changed N/A year-over-year to -$5.3 million in Q4 2022; TTM through Oct 2021 was $5.3 million, a N/A change from a year earlier, with the FY2022 full-year figure at $5.3 million, changed N/A from the prior year.
Acquisitions eased to -$5.3 million in Q4 2022 per IRIX's latest filing, from $5.3 million in the prior quarter.
Across five years, Acquisitions topped out at $5.3 million in Q2 2021 and bottomed at -$5.3 million in Q4 2022.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Acquisitions (Qtr)
1	Abbott Laboratories	201.40 Bn	194.75 Bn	6.27 Bn	-
2	Stryker	122.29 Bn	119.41 Bn	3.81 Bn	22.00 Mn
3	Medtronic	105.01 Bn	96.40 Bn	6.41 Bn	406.00 Mn
4	Boston Scientific	64.81 Bn	63.59 Bn	3.61 Bn	523.00 Mn
5	Edwards Lifesciences	55.28 Bn	51.60 Bn	1.29 Bn	-
6	Dexcom	29.06 Bn	27.94 Bn	750.30 Mn	-
7	Koninklijke Philips	29.02 Bn	25.93 Bn	2.07 Bn	-268.10 Mn
8	GE HealthCare Technologies	28.27 Bn	26.20 Bn	1.98 Bn	2.30 Bn
9	Smith & Nephew	25.80 Bn	25.22 Bn	-	-
10	Iridex	15.93 Mn	11.33 Mn	4.74 Mn	-

Download Data